https://www.marketwatch.com/story/moderna-rsv-vaccine-more-than-80-effective-study-shows-1c41e2e2
Moderna Inc.’s investigational vaccine for respiratory syncytial virus is 84% effective against the lower respiratory tract illness linked with the virus,...
Create an account or login to join the discussion